The salivary metatranscriptome as an accurate diagnostic indicator of oral cancer
- PMID: 34880265
- PMCID: PMC8654845
- DOI: 10.1038/s41525-021-00257-x
The salivary metatranscriptome as an accurate diagnostic indicator of oral cancer
Abstract
Despite advances in cancer treatment, the 5-year mortality rate for oral cancers (OC) is 40%, mainly due to the lack of early diagnostics. To advance early diagnostics for high-risk and average-risk populations, we developed and evaluated machine-learning (ML) classifiers using metatranscriptomic data from saliva samples (n = 433) collected from oral premalignant disorders (OPMD), OC patients (n = 71) and normal controls (n = 171). Our diagnostic classifiers yielded a receiver operating characteristics (ROC) area under the curve (AUC) up to 0.9, sensitivity up to 83% (92.3% for stage 1 cancer) and specificity up to 97.9%. Our metatranscriptomic signature incorporates both taxonomic and functional microbiome features, and reveals a number of taxa and functional pathways associated with OC. We demonstrate the potential clinical utility of an AI/ML model for diagnosing OC early, opening a new era of non-invasive diagnostics, enabling early intervention and improved patient outcomes.
© 2021. The Author(s).
Conflict of interest statement
The following authors are/were employees of Viome Inc, a commercial for-profit company, at the time of their contributions: G.B., O.O., R.T., S.R., F.C., P.J.T., S.G., M.P., A.P., H.T., and M.V. For the other authors there is no conflict of interest to the best of our knowledge.
Figures
References
-
- American Society of Clinical Oncology. Head and neck cancer guide. https://www.cancer.net/cancer-types/head-and-neck-cancer/introduction (2019).
-
- World Health Organization. Oral cancer. https://www.who.int/cancer/prevention/diagnosis-screening/oral-cancer/en/ (2020).
Grants and funding
LinkOut - more resources
Full Text Sources
